BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 29339316)

  • 1. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
    Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
    Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
    Kümpfel T; Giglhuber K; Aktas O; Ayzenberg I; Bellmann-Strobl J; Häußler V; Havla J; Hellwig K; Hümmert MW; Jarius S; Kleiter I; Klotz L; Krumbholz M; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Trebst C; Tumani H; Warnke C; Wildemann B; Berthele A;
    J Neurol; 2024 Jan; 271(1):141-176. PubMed ID: 37676297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.
    Hamid SH; Elsone L; Mutch K; Solomon T; Jacob A
    Mult Scler; 2017 Feb; 23(2):228-233. PubMed ID: 27553618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuromyelitis optica].
    Ferrán C; Pedemonte V; Turcatti E; González G
    Medicina (B Aires); 2019; 79 Suppl 3():60-65. PubMed ID: 31603846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
    Wingerchuk DM; Banwell B; Bennett JL; Cabre P; Carroll W; Chitnis T; de Seze J; Fujihara K; Greenberg B; Jacob A; Jarius S; Lana-Peixoto M; Levy M; Simon JH; Tenembaum S; Traboulsee AL; Waters P; Wellik KE; Weinshenker BG;
    Neurology; 2015 Jul; 85(2):177-89. PubMed ID: 26092914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the management of neuromyelitis optica spectrum disorder.
    Bruscolini A; La Cava M; Mallone F; Marcelli M; Ralli M; Sagnelli P; Greco A; Lambiase A
    Expert Rev Neurother; 2019 Nov; 19(11):1127-1133. PubMed ID: 31339052
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment.
    Baghbanian SM; Asgari N; Sahraian MA; Moghadasi AN
    J Neurol Sci; 2018 May; 388():222-231. PubMed ID: 29478727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options in neuromyelitis optica spectrum disorders.
    Kitley J; Palace J
    Expert Rev Neurother; 2016; 16(3):319-29. PubMed ID: 26840802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the treatment of neuromyelitis optica spectrum disorders related optic neuritis].
    Song HL; Xu QG; Wei SH
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):539-543. PubMed ID: 32842338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
    Bennett JL
    J Neuroophthalmol; 2016 Sep; 36(3):238-45. PubMed ID: 27529327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
    Alam M; Haq MAU; Iqbal A; Ullah K; Nabi D
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):379-380. PubMed ID: 30925966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
    Crout TM; Parks LP; Majithia V
    Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
    Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
    Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica (Devic's syndrome).
    Wingerchuk DM; Weinshenker BG
    Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.
    Sato DK; Lana-Peixoto MA; Fujihara K; de Seze J
    Brain Pathol; 2013 Nov; 23(6):647-60. PubMed ID: 24118482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].
    Aktas O; Kümpfel T
    Nervenarzt; 2021 Apr; 92(4):307-316. PubMed ID: 33728474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Neuromyelitis Optica Spectrum Disorders.
    Chan KH; Lee CY
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.